Evolutionary genomics and HIV restriction factors

Current Opinion in HIV and AIDS

Volumn 10, Issue 2, 2015, Pages 79-83

  Pyndiah, Nitisha ^a   Telenti, Amalio ^b   Rausell, Antonio ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b J CRAIG VENTER INSTITUTE   (United States)

Author keywords

HIV; Host pathogen coevolution; Innate immunity; Positive selection; Viral restriction factors

Indexed keywords

HIV RESTRICTION FACTOR; MYXOVIRUS RESISTANCE 2 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN; MYXOVIRUS RESISTANCE PROTEIN;

CELL DEATH; GENOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INNATE IMMUNITY; MOLECULAR EVOLUTION; NONHUMAN; ORTHOLOGY; PRIMATE; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS IMMUNITY; GENETICS; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; VIROLOGY; VIRUS GENOME;

EVOLUTION, MOLECULAR; GENOME, VIRAL; GENOMICS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MYXOVIRUS RESISTANCE PROTEINS;

EID: 84925882122     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000138     Document Type: Review

References (40)

1. Schoggins JW, Wilson SJ, Panis M, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011;472:481-485.
2. Schoggins JW, Macduff DA, Imanaka N, et al. Pan-viral specificity of IFNinduced genes reveals new roles for cGAS in innate immunity. Nature 2014;505:691-695.
3. Harris RS, Liddament MT. Retroviral restriction by APOBEC proteins. Nat Rev Immunol 2004;4:868-877.
4. Nakayama EE, Shioda T. Antiretroviral activity of TRIM5 alpha. Rev Med Virol 2010;20:77-92.
5. Perez-Caballero D, Zang T, Ebrahimi A, et al. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 2009;139:499-511.
6. Zhang F, Wilson SJ, Landford WC, et al. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 2009;6:54-67.
7. Le Tortorec A, Neil SJ. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J Virol 2009;83:11966-11978.
8. Laguette N, Sobhian B, Casartelli N, et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011;474:654-657.
9. Lahouassa H, Daddacha W, Hofmann H, et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 2012;13:223-228.
10. Busnadiego I, Kane M, Rihn SJ, et al. Host and viral determinants of Mx2 antiretroviral activity. J Virol 2014;88:7738-7752. This study maps a key residue for the activity of MX2 using species specificity, positive selection and chimeras.
11. Goujon C, Moncorgé O, Bauby H, et al. Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor. J Virol 2014;88:9017-9026.
12. Liu Z, Pan Q, Ding S, et al. The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 2013;14:398-410. References [12] and [13] describe a new HIV-1 restriction factor.
13. Goujon C, Moncorge O, Bauby H, et al. Human MX2 is an interferon-induced postentry inhibitor of HIV-1 infection. Nature 2013;502:559-562. References [12] and [13] describe a new HIV-1 restriction factor.
14. Malim MH, Bieniasz PD. HIV restriction factors and mechanisms of evasion. Cold Spring Harb Perspect Med 2012;2:a006940.
15. Tamura K, Stecher G, Peterson D, et al. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 2013;30:2725-2729.
16. Yang Z. PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol 2007;24:1586-1591.
17. Vitti JJ, Grossman SR, Sabeti PC. Detecting natural selection in genomic data. Ann Rev Genet 2013;47:97-120.
18. Nielsen R. Molecular signatures of natural selection. Ann Rev Genet 2005;39:197-218.
19. Moretti S, Laurenczy B, Gharib WH, et al. Selectome update: quality control and computational improvements to a database of positive selection. Nucleic Acids Res 2014;42:D917-921.
20. Li MJ, Wang LY, Xia Z, et al. dbPSHP: a database of recent positive selection across human populations. Nucleic Acids Res 2014;42:D910-D916.
21. Pybus M, Dall'Olio GM, Luisi P, et al. 1000 genomes selection browser 1.0: a genome browser dedicated to signatures of natural selection in modern humans. Nucleic Acids Res 2014;42:D903-D909.
22. Rausell A, McLaren PJ, Telenti A. HIV and innate immunity: a genomics perspective. F1000Prime Rep 2013;5:29.
23. Rausell A, Telenti A. Genomics of host-pathogen interactions. Curr Opin Immunol 2014;30 C: 32-38.
24. Meyerson NR, Rowley PA, Swan CH, et al. Positive selection of primate genes that promote HIV-1 replication. Virology 2014;454-455:291-298.
25. Daugherty MD, Malik HS. Rules of engagement: molecular insights from host-virus arms races. Ann Rev Genet 2012;46:677-700.
26. Kane M, Yadav SS, Bitzegeio J, et al. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 2013;502:563-566.
27. Goldschmidt V, Bleiber G, May M, et al. Role of common human TRIM5alpha variants in HIV-1 disease progression. Retrovirology 2006;3:54.
28. Newman RM, Hall L, Kirmaier A, et al. Evolution of a TRIM5-CypA splice isoform in old world monkeys. PLoS Pathog 2008;4:e1000003.
29. Duggal NK, Emerman M. Evolutionary conflicts between viruses and restriction factors shape immunity. Nat Rev Immunol 2012;12:687-695.
30. Unterholzner L, Keating SE, Baran M, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010;11:997-1004.
31. Jakobsen MR, Bak RO, Andersen A, et al. IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc Natl Acad Sci U S A 2013;110::E4571-4580. This study identifies a new antiviral protein able to block the replication of HIV by DNA sensing.
32. Monroe KM, Yang Z, Johnson JR, et al. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 2014;343:428-432.
33. Gaiha GD, Brass AL. Immunology. The fiery side of HIV-induced T cell death. Science 2014;343:383-384.
34. Thompson MR, Sharma S, Atianand M, et al. Interferon gamma-inducible Protein (IFI) 16 transcriptionally regulates Type I interferons and other interferonstimulated genes and controls the interferon response to both DNA and RNA viruses. J Biol Chem 2014;289:23568-23581.
35. Daugherty MD, Young JM, Kerns JA, Malik HS. Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts. PLoS Genet 2014;10:e1004403. This study describes an evolutionary approach to identify new antiviral proteins.
36. Malfavon-Borja R, Sawyer SL, Wu LI, et al. An evolutionary screen highlights canonical and noncanonical candidate antiviral genes within the primate TRIM gene family. Genome Biol Evol 2013;5:2141-2154.
37. Sawyer SL, Wu LI, Emerman M, Malik HS. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci U S A 2005;102:2832-2837.
38. Laguette N, Rahm N, Sobhian B, et al. Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe 2012;11:205-217.
39. Lim ES, Fregoso OI, McCoy CO, et al. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 2012;11:194-204.
40. Malim MH, Emerman M. HIV-1 Accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 2008;3:388-398.